・Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases.
・Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results.
・Integrated autoloader and BD FACSChorus™ Software speeds time to insight for new and experienced users. MILFORD, Mass., Sept. 14, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced the global commercial launch of the BD FACSDiscover™ A7 Cell A…READ FULL ARTICLE